Info for Students » Uncategorized

Aarkstore announces, a new market research report is available in its vast collection:Boceprevir – Key patent, SPC, and data exclusivity expiry (7 country coverage)–151017.htmlPipeline Selector helps you avoid hours of painstaking reserach by quickly providing you with an accurate snapshot of a single INN, including key patents, extensions and data exclusivity expiry for 7 countries (44 country coverage also available), regulatory issues and key players.This Pipeline Selector report covers BoceprevirBoceprevir indications: Treatment of chronic hepatitis C (CHC) genotype 1, in combination with Peginterferon alfa and RibavirinBoceprevir Merck (Victrelis)Examples of information found in this online report include:# Includes key patent publications for 7 countries (see list below)# Contains SPC protection for every EU state plus patent term extensions in other countries# Data exclusivity calculated on a country by country basis# Summary of dosage forms, strengths, indications and active ingredient forms of the brand product# DMF & Paragraph IV filings# Litigation alerts# Marketing authorisation holders in selected territories# Patent risk analysis via graphical display of data from patent filings# Hyper-linking to crucial patent documents and national registries enabling data verificationThe Key Patent Indicator enables easy identification of key patent, SPC and data protection expiry information covering 7 countries, including extension details (SPC and national law)(also available with 44 country coverage):Pipeline Selector 7 Country Coverage:Country Region ExtensionsAustralia Asia-Pacific S70Canada Americas N/AUSA Americas S156Germany Western Europe SPCGreat Britain Western Europe SPCSFrance Western Europe NAT/SPCSpain Western Europe SPCOther key information contained in the report:# Summary of dosage forms, strengths, indications and active ingredient forms of the brand product in major countries**.# News articles# Litigation alerts# Marketing authorisation holders for Great Britain, the United States, Canada and Australia enable you to see who is active in the market.# US Drug Master Files, providing valuable information to help source active ingredients and keep an eye on competitors.# Paragraph IV filing; details of US ANDAs filed with a Paragraph IV certification allow easy determination of who the first movers are for a particular generic product in the US.# Patent Risk Analysis section containing three graphical displays of data drawn from known patent filings to provide valuable competitor insight and development information***.*Key Patent IndicatorThe Key Patent Indicator section is intended only to provide an indication of the Key Patents pertaining to a generic drug, and is not based on a comprehensive patent search (a comprehensive patent search can be found in the corresponding Pipeline Selector report).For More Related Reports Please follow the link Aarkstore EnterpriseContact: VinaMob.No.918149852585Email: URL: Advertisement

Comments are closed.